Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in September 2000, RiverVest Venture Partners is a prominent venture capital firm headquartered in St. Louis, Missouri, with additional offices in San Diego, California, and Cleveland, Ohio. The firm specializes in building life science companies that tackle significant unmet medical needs, primarily in the biopharma and medical device sectors. RiverVest has established a reputation for its strategic approach to investing, which includes leading financings, founding companies, and assembling strong investor syndicates. With a focus on managing risk effectively, RiverVest aims to achieve high hit rates in its investments.
Over the years, RiverVest has raised multiple funds and has developed a robust portfolio of companies that have made significant impacts in their respective fields. The firm’s leadership comprises experienced professionals with deep expertise in life sciences, enabling them to provide valuable insights and support to their portfolio companies. RiverVest's commitment to innovation and excellence has positioned it as a key player in the venture capital landscape, particularly within the healthcare sector.
RiverVest Venture Partners concentrates its investments in the biopharma and medical device sectors, with a particular emphasis on products that have a clear path to clinical approval. The firm seeks to invest in companies that can demonstrate safety and efficacy in early clinical trials, which is critical for success in the highly regulated healthcare environment. RiverVest's investment strategy includes leading financings and founding companies, which allows them to take an active role in shaping the direction of their portfolio companies.
In terms of investment stages, RiverVest engages with startups at various points in their development, including seed, Series A, Series B, and growth equity stages. The firm typically invests in companies that are addressing significant medical needs and have the potential to make a meaningful impact on patient care. RiverVest looks for founders who are not only passionate about their innovations but also possess the expertise and vision necessary to navigate the complexities of the healthcare landscape.
RiverVest Venture Partners boasts a strong portfolio of notable investments, particularly in the life sciences sector. Among its most distinguished portfolio companies is **Good Therapeutics**, which was acquired by Roche in 2022 for $250 million upfront, with additional milestone payments potentially increasing the total value of the deal. Another significant investment is **Standard Bariatrics**, which was acquired by Teleflex in 2022 for $170 million, along with further milestone payments. Additionally, RiverVest co-founded **Lumena Pharmaceuticals**, which was acquired by Shire in 2014, focusing on innovative therapies for rare liver diseases.
The firm’s strategic investments have not only yielded substantial financial returns but have also contributed to advancements in healthcare, showcasing RiverVest's commitment to supporting companies that address critical medical challenges. The successful exits from these investments highlight RiverVest's ability to identify and nurture promising startups in the biotech and healthcare sectors.
To pitch RiverVest Venture Partners, founders should email info@rivervest.com. It is recommended to include a succinct overview of the business, highlighting the product, market opportunity, and team. RiverVest is open to both warm introductions and cold applications, but a well-prepared pitch is essential for capturing their interest.
RiverVest Venture Partners invests across multiple stages, including seed, Series A, Series B, and growth equity. This diverse stage focus allows them to support companies at various points in their development, from early-stage startups to more established firms seeking growth capital.
Founders interested in pitching RiverVest can reach out via email at info@rivervest.com. It is advisable to provide a clear and concise overview of your business, including your product, market opportunity, and team, to capture their interest effectively.
RiverVest primarily focuses on the biopharma and medical device sectors. They seek to invest in companies that are developing innovative solutions to significant unmet medical needs, particularly those with a clear path to clinical approval.
While specific check sizes are not disclosed, RiverVest typically leads financings and invests in companies at various stages, which suggests they are flexible in their investment amounts based on the needs of the startup and the stage of development.
RiverVest Venture Partners primarily invests in North America. Their offices in St. Louis, San Diego, and Cleveland enable them to engage with a wide range of life science companies across the region.
RiverVest offers extensive support to its portfolio companies, leveraging its network and expertise in the life sciences sector. This includes guidance on navigating clinical trials, strategic advice, and assistance in building strong investor syndicates.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.